PHP
AXGN icon

Parkman Healthcare Partners’s Axogen AXGN Stock Holding History

Parkman Healthcare Partners’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-268,160
Closed -$8.88M – 82
2026
Q1 		$8.88M Buy
268,160
+17,842
+7% +$580K 0.92% 41
2025
Q4 		$8.19M Sell
250,318
-251,514
-50% -$6.19M 0.78% 44
2025
Q3 		$8.95M Sell
501,832
-172,719
-26% -$2.51M 0.93% 38
2025
Q2 		$7.32M Buy
674,551
+137,719
+26% +$1.8M 0.84% 45
2025
Q1 		$9.93M Buy
536,832
+171,129
+47% +$3.09M 1.18% 30
2024
Q4 		$6.03M Sell
365,703
-47,185
-11% -$668K 0.8% 42
2024
Q3 		$5.79M Buy
+412,888
New +$4.57M 0.74% 47
2023
Q3 		– Sell
-260,858
Closed -$2.38M – 103
2023
Q2 		$2.38M Buy
260,858
+37,075
+17% +$346K 0.41% 69
2023
Q1 		$2.11M Buy
223,783
+33,728
+18% +$308K 0.46% 56
2022
Q4 		$1.9M Sell
190,055
-9,945
-5% -$110K 0.51% 58
2022
Q3 		$2.38M Buy
200,000
+11,506
+6% +$115K 0.68% 52
2022
Q2 		$1.54M Buy
188,494
+59,547
+46% +$509K 0.57% 48
2022
Q1 		$1.02M Sell
128,947
-77,651
-38% -$671K 0.3% 67
2021
Q4 		$1.94M Buy
206,598
+6,598
+3% +$79.1K 0.43% 60
2021
Q3 		$3.16M Sell
200,000
-37,652
-16% -$676K 0.8% 37
2021
Q2 		$5.14M Buy
237,652
+26,053
+12% +$527K 1.12% 34
2021
Q1 		$4.29M Sell
211,599
-18,910
-8% -$373K 1% 34
2020
Q4 		$4.13M Buy
230,509
+105,509
+84% +$1.55M 1.06% 39
2020
Q3 		$1.45M Buy
+125,000
New +$1.45M 0.39% 66

Other funds holding AXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Parkman Healthcare Partners's AXGN Position: Q2 2026 in Review

Parkman Healthcare Partners sold out of Axogen (AXGN) in Q2 2026, closing a stake of 268,160 shares — an estimated $8.88M sold.

Parkman Healthcare Partners first reported a position in AXGN in Q3 2020 and held it in 19 quarters. The position peaked at $9.93M in Q1 2025. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Parkman Healthcare Partners reported no remaining Axogen position as of Q2 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 268,160 Axogen shares in Q2 2026, an estimated $8.88M.
  • Parkman Healthcare Partners first reported a position in Axogen in Q3 2020 and held it in 19 quarters.
  • Parkman Healthcare Partners's Axogen position peaked at $9.93M in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.